Integrating Malaria Vaccine With Seasonal Malaria Chemoprevention in West Africa

Clinical trial NCT06860178 · RECRUITING

Trial details

NCT number: NCT06860178
Sponsor: Epicentre
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Malaria Vaccine

Start date: 2025-06-10
Primary completion: 2026-05-01
Enrollment: 40000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.